We are live on ! Find out more
REVB icon

Revelation Biosciences
REVB

4 hedge funds and large institutions have $84.3K invested in Revelation Biosciences in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0% less ownership

Funds ownership: 0.02% → 0.01% (-0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

12% less capital invested

Capital invested by funds: $95.8K → $84.3K (-$11.5K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$53K
2
UBS Group
UBS Group
Switzerland
+$17.1K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16.6K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$32K
2
TRCT
Tower Research Capital (TRC)
New York
-$3.13K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2K

REVB Hedge Fund Activity: Q3 2024 in Review

4 of the 6,970 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences (REVB) for Q3 2024, worth a combined $84.3K — down 12% from $95.8K a quarter earlier.

Fund positioning in REVB was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $53K. The largest seller was HRT Financial, exiting entirely with an estimated $32K sold.

  • 4 institutional investors held Revelation Biosciences (REVB) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $84.3K of Revelation Biosciences stock for Q3 2024, down 12% quarter-over-quarter.
  • 2 funds opened new Revelation Biosciences positions in Q3 2024 and 2 closed out, a net change of 0 holders.
  • The largest Revelation Biosciences buyer in Q3 2024 was Sabby Management, an estimated $53K added.
  • The largest Revelation Biosciences seller in Q3 2024 was HRT Financial, an estimated $32K sold.

Based on aggregated 13F filings for Q3 2024.